Neuroimaging of vessel amyloid in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 242-247

  Friedland, Robert P ^a   Kalaria, Rajesh ^a   Berridge, Marc ^a   Miraldi, Floro ^a   Hedera, Peter ^a,b   Reno, John ^c   Lyle, Eon ^d   Marotta, Charles A ^e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Poniard Pharmaceuticals Inc   (United States)

^d MALLINCKRODT PHARMACEUTICALS   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; CROSS REACTING ANTIBODY; MONOCLONAL ANTIBODY; RADIOISOTOPE; TECHNETIUM 99M;

ADULT; AGED; ALZHEIMER DISEASE; BONE MARROW; BRAIN BLOOD VESSEL; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CONFERENCE PAPER; HALF LIFE TIME; HEAD; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSCINTIGRAPHY; SCALP; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030725888     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48475.x     Document Type: Conference Paper

References (30)

1. DELA Torre, J. C. 1994. Impaired brain microcirculation may trigger Alzheimer's disease. Neurose. Biobehav. Rev. 18(3): 397-401.
2. SCHOLZ, W. 1938. Studien zur pathologie der hirngefassse. II. Die drusige entartung der hirnarterien und capillaren. Z. Neurol. Psychiat. 162: 694-715.
3. ELLIS, R. J. et al. 1996. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV. Neurology 46: 1592-1596.
4. FRIEDLAND, R. P. et al. 1991. Anti-amyloid antibodies for in-vivo diagnosis of Alzheimer's disease. Neurology 41(Suppl. 1): 156.
5. FRIEDLAND, R. P. et al. 1991. Anti-amyloid antibodies for in-vivo immunocytochemical studies of Alzheimer's disease using neuroimaging. J. Cereb. Blood Flow Metabo. 11(Suppl. 2): S186.
6. FRIEDLAND, R. P. et al. 1993. Development of a monoclonal antibody targeting the amyloid β protein for immunochemical neuroimaging. Neurology 43: A213.
7. FRIEDLAND, R. P. et al. 1993. Immunochemistry of Alzheimer's disease: Development of a monoclonal antibody targeting the amyloid β protein for neuroimaging. J. Cereb. Blood Flow Metab. 13: S244.
8. FRIEDLAND, R. P. et al. 1994. Imaging studies of a TC-99 anti Aβ Fab monoclonal antibody (MAB) in Alzheimer's disease (AD) using SPECT. Soc. Neurosci. Abstr. 20: 1057.
9. FRIEDLAND, R. P. et al. 1994. Noninvasive imaging using a murine monoclonal anti-Aβ antibody Fab labeled with technetium 99m in Alzheimer's disease. Neurobiol. Aging 15(Suppl. 1): S96-S97.
10. MAROTTA, C. A. et al. 1995. Imaging studies with murine anti Aβ monoclonal antibody (MAB) Fab 10H3 in Alzheimer's disease (AD) patients. Neurology 45(Suppl 4): A405. (Presented at the American Academy of Neurology, Seattle, WA, May 1995.)
11. MAJOCHA, R. E. et al. 1992. Development of a monoclonal antibody specific for β/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy. J. Nucl. Med. 33: 2184-2189.
12. FRIEDLAND, R. P. et al. 1994. Development of an anti-Aβ monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease. Mol. Neurobiol. 9:107-113.
13. YAMAGUCHI, H. et al. 1992. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am J. Pathol. 141: 249-259.
14. ZAIN, S. B. et al. 1988. Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer disease brain: Coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex. Proc. Natl. Acad. Sci. USA 85(3): 929-933.
15. MAJOCHA, R. E. 1988. Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer's disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 85(16): 6182-6186.
16. FRITZBERG, A. R. et al. 1986. Synthesis and biological evaluation of technetium-99m MG3 as a hippuran replacement. J. Nucl. Med. 27(1): 111-116.
17. KRAMER, E. L. et al. 1993. Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: Phase I study. J. Nucl. Med. 34: 1067-1074.
18. PHILPOTT, G. W. et al. 1995. RadioimmunoPET: Detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J. Nucl. Med. 36: 1818-1824.
19. EARY, J. F. et al. 1989. Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies. J. Nucl. Med. 30(1): 25-32.
20. FRIEDLAND, R. P. et al. 1983. Quantitative evaluation of blood brain barrier integrity in Alzheimer-type dementia: Positron emission tomographic studies with rubidium-82. Eur. Neurol. 22(Suppl. 2): 19-20.
21. SCHLAGETER, N. L., R. E. CARSON & S. I. RAPOPORT. 1987. Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga] EDTA and positron emission tomography. J. Cereb. Blood Flow Metab. 7(1): 1-8.
22. MAY, C. 1990. Cerebrospinal fluid production is reduced in healthy aging. Neurology 40: 500-503.
23. IKEDA, M. et al. 1993. Diagnostic significance of skin immunolabelling with antibody against native cerebral amyloid in Alzheimer's disease. Neurosci. Lett. 150: 159-161.
24. MAGGIO, J. E. et al. 1992. Reversible in vitro growth of Alzheimer disease /3-amyloid plaques by deposition of labeled amyloid peptide. Proc. Natl. Acad. Sci. USA 89:5462-5466.
25. MANTYH, P. W. et al. 1991. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques. Bull. Clin. Neurosci. 56: 73-85.
26. SAITO, Y. et al. 1995. Vector mediated delivery of I-125-labeled beta-amyloid peptide A-beta (1-40) through the blood-brain barrier and binding to Alzheimer disease amyloid of the A-beta (1-40)/vector complex. Proc. Natl. Acad. Sci. USA 92: 10227-10231.
27. ZLOKOVIC, B. V. et al. 1993. Blood-brain barrier transport of circulating Alzheimer's amyloid β. Biochem. Biophys. Res. Commun. 197: 1034-1040.
28. ZLOKOVIC, B. V. et al. 1994. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem. Biophys. Res. Commun. 205: 1431-1437.
29. GHILARDI, J. R. Intra-arterial infusion of 125I-Aβ1-40 labels amyloid deposits in the aged primate brain in vivo. NeuroReport. In press.
30. WALKER, L. C. et al. 1994. Labeling of cerebral amyloid in vivo with a monoclonal antibody. J. Neuropath. Exp. Neurol. 53(4): 377-383.